Alecensa 150MG 240S
Ended Awarded
- Contract number
- SPE2DX25FKVZE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,782
Award facts
- Contract value 100% obligated
- $12,782.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $12,782.32 for 240 tablets of Alecensa 150mg. The award, issued on August 28, 2025, with an ultimate completion date of September 18, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
Alecensa (alectinib) is a targeted cancer therapy used primarily in the treatment of non-small cell lung cancer. This delivery order represents a routine pharmaceutical supply transaction through DMS Pharmaceutical Group's established federal contract vehicle, reflecting the company's consistent role as a critical supplier within the Defense Logistics Agency's pharmaceutical supply chain. The firm fixed-price structure and accelerated timeline indicate urgent medical supply requirements to support military health facilities.
Quick answers
Who was awarded contract SPE2DX25FKVZE?
SPE2DX25FKVZE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 28, 2025.
How much is contract SPE2DX25FKVZE worth?
The government has obligated $12,782 on SPE2DX25FKVZE.
Is contract SPE2DX25FKVZE an order under another contract?
Yes. SPE2DX25FKVZE is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVZE competed?
The extent of competition for SPE2DX25FKVZE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award